Financhill
Sell
35

NWSA Quote, Financials, Valuation and Earnings

Last price:
$22.72
Seasonality move :
-4.82%
Day range:
$22.31 - $22.77
52-week range:
$22.20 - $31.61
Dividend yield:
0.88%
P/E ratio:
29.53x
P/S ratio:
1.49x
P/B ratio:
1.43x
Volume:
3.4M
Avg. volume:
4M
1-year change:
-23.01%
Market cap:
$12.6B
Revenue:
$8.5B
EPS (TTM):
$0.77
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Revenue $9.4B $10.4B $9.9B $8.3B $8.5B
Revenue Growth (YoY) 3.89% 10.98% -4.87% -16.47% 2.42%
 
Cost of Revenues $5.5B $5.8B $5.8B $4.3B $4.2B
Gross Profit $3.8B $4.6B $4B $4B $4.3B
Gross Profit Margin 41.1% 44.04% 40.91% 48.45% 50.37%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.3B $3.6B $3.3B $3.5B $3.3B
Other Inc / (Exp) -$90M -$70M -$245M -$198M -$36M
Operating Expenses $3.2B $3.6B $3.3B $3.2B $3.3B
Operating Income $602M $992M $722M $809M $965M
 
Net Interest Expenses $37M $105M $84M $35M $10M
EBT. Incl. Unusual Items $450M $812M $330M $585M $923M
Earnings of Discontinued Ops. -- -- -- -$3M $700M
Income Tax Expense $61M $52M $143M $206M $275M
Net Income to Company $389M $760M $187M $354M $1.3B
 
Minority Interest in Earnings $59M $137M $38M $110M $168M
Net Income to Common Excl Extra Items $389M $760M $187M $379M $648M
 
Basic EPS (Cont. Ops) $0.56 $1.06 $0.26 $0.47 $0.82
Diluted EPS (Cont. Ops) $0.56 $1.05 $0.26 $0.46 $0.81
Weighted Average Basic Share $590.4M $589.5M $576.4M $571.2M $567.7M
Weighted Average Diluted Share $593.4M $592.5M $578.8M $573.5M $569.9M
 
EBITDA $1.4B $1.8B $1.5B $1.2B $1.4B
EBIT $602M $992M $722M $809M $965M
 
Revenue (Reported) $9.4B $10.4B $9.9B $8.3B $8.5B
Operating Income (Reported) $602M $992M $722M $809M $965M
Operating Income (Adjusted) $602M $992M $722M $809M $965M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $2.7B $2.5B $2.1B $2.2B $2.4B
Revenue Growth (YoY) 12.55% -7.21% -15.31% 4.82% 5.54%
 
Cost of Revenues $1.4B $1.5B $1.1B $1.1B $1.1B
Gross Profit $1.3B $1.1B $1.1B $1.2B $1.2B
Gross Profit Margin 46.74% 41.77% 49.42% 51.79% 52.33%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $852M $818M $832M $797M $833M
Other Inc / (Exp) -$36M -$54M $8M $68M --
Operating Expenses $848M $818M $763M $793M $833M
Operating Income $422M $235M $292M $366M $403M
 
Net Interest Expenses $17M $26M $3M -- --
EBT. Incl. Unusual Items $361M $155M $291M $430M $367M
Earnings of Discontinued Ops. -- -- -$4M -$13M --
Income Tax Expense $99M $61M $97M $124M $125M
Net Income to Company $262M $94M $183M $283M $242M
 
Minority Interest in Earnings $27M $27M $34M $78M $49M
Net Income to Common Excl Extra Items $262M $94M $194M $306M $242M
 
Basic EPS (Cont. Ops) $0.40 $0.12 $0.27 $0.38 $0.34
Diluted EPS (Cont. Ops) $0.40 $0.12 $0.27 $0.38 $0.34
Weighted Average Basic Share $592.1M $576M $571.9M $568.5M $560.6M
Weighted Average Diluted Share $594.7M $578M $573.5M $570.1M $562M
 
EBITDA $622M $436M $402M $479M $521M
EBIT $422M $235M $292M $366M $403M
 
Revenue (Reported) $2.7B $2.5B $2.1B $2.2B $2.4B
Operating Income (Reported) $422M $235M $292M $366M $403M
Operating Income (Adjusted) $422M $235M $292M $366M $403M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $10B $10.2B $9.5B $8.4B $8.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.7B $5.9B $5.4B $4.2B $4.2B
Gross Profit $4.4B $4.3B $4.1B $4.2B $4.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.6B $3.6B $3.4B $3.5B $3.4B
Other Inc / (Exp) -$15M -$246M -$215M -$65M --
Operating Expenses $3.5B $3.6B $3.3B $3.3B $3.4B
Operating Income $833M $734M $801M $917M $1B
 
Net Interest Expenses $74M $79M $55M $35M --
EBT. Incl. Unusual Items $731M $369M $460M $846M $862M
Earnings of Discontinued Ops. -- -- -$4M -$17M $712M
Income Tax Expense $121M -$22M $181M $260M $277M
Net Income to Company $610M $391M $268M $540M $1.3B
 
Minority Interest in Earnings $114M $92M $47M $155M $146M
Net Income to Common Excl Extra Items $610M $391M $279M $586M $585M
 
Basic EPS (Cont. Ops) $0.84 $0.51 $0.40 $0.73 $0.77
Diluted EPS (Cont. Ops) $0.83 $0.51 $0.40 $0.73 $0.77
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $1.6B $1.6B $1.5B $1.4B $1.5B
EBIT $833M $734M $801M $917M $1B
 
Revenue (Reported) $10B $10.2B $9.5B $8.4B $8.6B
Operating Income (Reported) $833M $734M $801M $917M $1B
Operating Income (Adjusted) $833M $734M $801M $917M $1B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $5.2B $5B $4.6B $4.3B $4.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.9B $2.9B $2.5B $2.1B $2.2B
Gross Profit $2.4B $2.1B $2.1B $2.2B $2.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.7B $1.7B $1.7B $1.7B $1.7B
Other Inc / (Exp) $79M -$97M -$67M $64M --
Operating Expenses $1.7B $1.7B $1.6B $1.6B $1.7B
Operating Income $669M $411M $495M $581M $627M
 
Net Interest Expenses $41M $31M $19M $12M --
EBT. Incl. Unusual Items $699M $256M $386M $640M $579M
Earnings of Discontinued Ops. -- -- -$4M -$12M --
Income Tax Expense $170M $96M $134M $185M $187M
Net Income to Company $529M $160M $241M $427M $392M
 
Minority Interest in Earnings $98M $53M $62M $109M $87M
Net Income to Common Excl Extra Items $529M $160M $252M $455M $392M
 
Basic EPS (Cont. Ops) $0.73 $0.19 $0.33 $0.59 $0.54
Diluted EPS (Cont. Ops) $0.72 $0.18 $0.32 $0.59 $0.54
Weighted Average Basic Share $1.2B $1.2B $1.1B $1.1B $1.1B
Weighted Average Diluted Share $1.2B $1.2B $1.1B $1.1B $1.1B
 
EBITDA $1.1B $821M $800M $806M $862M
EBIT $669M $411M $495M $581M $627M
 
Revenue (Reported) $5.2B $5B $4.6B $4.3B $4.5B
Operating Income (Reported) $669M $411M $495M $581M $627M
Operating Income (Adjusted) $669M $411M $495M $581M $627M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Cash and Equivalents $2.2B $1.8B $1.8B $1.9B $2.4B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.5B $1.5B $1.4B $1.4B $1.6B
Inventory $253M $311M $311M $266M $327M
Prepaid Expenses -- -- -- -- --
Other Current Assets $469M $458M $484M $474M $519M
Total Current Assets $4.5B $4.1B $4.1B $4.4B $4.8B
 
Property Plant And Equipment $3.3B $3B $3.1B $2.1B $2.1B
Long-Term Investments $369M $549M $492M $743M $1.3B
Goodwill $4.7B $5.2B $5.1B $4.3B $4.4B
Other Intangibles $2.2B $2.7B $2.5B $1.9B $1.9B
Other Long-Term Assets $793M $706M $674M $2.4B $138M
Total Assets $16.8B $17.2B $16.9B $16.7B $15.5B
 
Accounts Payable $321M $411M $440M $254M $335M
Accrued Expenses $1.3B $1.2B $1.1B $986M $1B
Current Portion Of Long-Term Debt -- $266M -- $9M $2M
Current Portion Of Capital Lease Obligations $171M $166M $139M $89M $97M
Other Current Liabilities $694M $603M $524M $1B $438M
Total Current Liabilities $3.2B $3.5B $3.2B $3.1B $2.6B
 
Long-Term Debt $3.4B $3.7B $4.1B $3B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $7.6B $8.1B $8B $7.7B $6.1B
 
Common Stock $6M $6M $6M $6M $6M
Other Common Equity Adj -$941M -$1.3B -$1.2B -$1.3B -$1.5B
Common Equity $8.2B $8.2B $8.1B $8.1B $8.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $935M $921M $881M $891M $615M
Total Equity $9.1B $9.1B $8.9B $9B $9.4B
 
Total Liabilities and Equity $16.8B $17.2B $16.9B $16.7B $15.5B
Cash and Short Terms $2.2B $1.8B $1.8B $1.9B $2.4B
Total Debt $3.4B $4B $4.1B $3B $2.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $2.2B $1.3B $1.7B $1.8B $2.1B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.7B $1.6B $1.5B $1.7B $1.9B
Inventory $248M $328M $297M $296M $306M
Prepaid Expenses -- -- -- -- --
Other Current Assets $502M $471M $466M $554M --
Total Current Assets $4.6B $3.8B $4B $6.5B $4.6B
 
Property Plant And Equipment $3.1B $3.1B $3B $2B $2.1B
Long-Term Investments $553M $524M $436M $669M $1.3B
Goodwill $4.6B $5.2B $5.2B $4.3B --
Other Intangibles $2.1B $2.6B $2.4B $1.9B --
Other Long-Term Assets $718M $714M $631M $422M --
Total Assets $16.5B $16.9B $16.7B $16.2B $15.5B
 
Accounts Payable $351M $308M $243M $365M $425M
Accrued Expenses $1.1B $1.1B $1.1B $832M --
Current Portion Of Long-Term Debt $276M -- $33M $19M --
Current Portion Of Capital Lease Obligations $169M $138M $136M $84M --
Other Current Liabilities $590M $601M $514M $1.8B --
Total Current Liabilities $3.2B $2.9B $2.8B $3.7B $2.5B
 
Long-Term Debt $3B $4.1B $4.1B $2.8B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $7.2B $7.8B $7.6B $7.1B $6B
 
Common Stock $6M $6M $6M $6M $6M
Other Common Equity Adj -$1.1B -$1.3B -$1.2B -$1.4B --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $964M $941M $920M $876M $670M
Total Equity $9.3B $9.1B $9.1B $9B $9.5B
 
Total Liabilities and Equity $16.5B $16.9B $16.7B $16.2B $15.5B
Cash and Short Terms $2.2B $1.3B $1.7B $1.8B $2.1B
Total Debt $3.3B $4.1B $4.1B $2.8B $2.8B
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders $389M $760M $187M $354M $1.3B
Depreciation & Amoritzation $808M $813M $823M $440M $459M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$166M -$51M -$181M -$85M -$96M
Change in Inventories $6M -$87M -$2M $27M -$46M
Cash From Operations $1.2B $1.4B $1.1B $1.1B $1.1B
 
Capital Expenditures $390M $499M $499M $357M $407M
Cash Acquisitions $886M $1.5B $17M $38M $96M
Cash From Investing -$1.3B -$2.1B -$574M -$524M -$153M
 
Dividends Paid (Ex Special Dividend) $163M $175M $174M $172M $185M
Special Dividend Paid
Long-Term Debt Issued $1.5B $1.7B -- $278M $61M
Long-Term Debt Repaid -$557M -$838M -$65M -$409M -$203M
Repurchase of Common Stock -- $179M $243M $117M $150M
Other Financing Activities -$96M -$94M -$43M -$63M -$47M
Cash From Financing $699M $404M -$501M -$441M -$563M
 
Beginning Cash (CF) $2.2B $1.8B $1.8B $1.9B $2.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $719M -$414M $11M $127M $443M
Ending Cash (CF) $3B $1.3B $1.8B $2B $2.9B
 
Levered Free Cash Flow $847M $855M $593M $741M $727M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $262M $94M $183M $283M $242M
Depreciation & Amoritzation $200M $201M $16M $11M $118M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$231M -$255M $49M -$140M --
Change in Inventories $65M $50M $78M $37M $34M
Cash From Operations $362M $192M $359M $304M $230M
 
Capital Expenditures $107M $113M $30M $62M $99M
Cash Acquisitions $21M $12M -- $1M $56M
Cash From Investing -$154M -$207M -$119M $37M -$150M
 
Dividends Paid (Ex Special Dividend) $59M $58M $57M $57M $57M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $117M $79M -$652M -$92M --
Long-Term Debt Repaid -$117M -$125M $665M -$11M --
Repurchase of Common Stock $43M $51M $27M $40M $172M
Other Financing Activities -$11M -$8M -$39M $5M --
Cash From Financing -$113M -$163M -$79M -$206M -$240M
 
Beginning Cash (CF) $2.2B $1.3B $1.7B $1.8B $2.1B
Foreign Exchange Rate Adjustment -$11M $48M $34M -$67M $13M
Additions / Reductions $84M -$130M $195M $68M -$147M
Ending Cash (CF) $2.3B $1.2B $2B $1.8B $1.9B
 
Levered Free Cash Flow $255M $79M $329M $242M $131M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $610M $391M $268M $540M $1.3B
Depreciation & Amoritzation $810M $826M $624M $352M $469M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$216M -$180M $91M -$253M --
Change in Inventories -$15M -$104M $32M $17M $16M
Cash From Operations $1.2B $1.1B $1.2B $1.2B $1.1B
 
Capital Expenditures $427M $506M $436M $340M $430M
Cash Acquisitions $817M $1.5B $22M $31M $180M
Cash From Investing -$1.3B -$2.2B -$515M -$345M -$305M
 
Dividends Paid (Ex Special Dividend) $169M $178M $170M $179M $197M
Special Dividend Paid
Long-Term Debt Issued $1.9B $1.6B -$134M $66M --
Long-Term Debt Repaid -$809M -$800M $129M -$337M --
Repurchase of Common Stock $43M $314M $121M $139M $336M
Other Financing Activities -$123M -$20M -- -$61M --
Cash From Financing $720M $290M -$333M -$650M -$629M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $622M -$856M $396M $122M $205M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $757M $579M $799M $823M $646M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $529M $160M $241M $427M $392M
Depreciation & Amoritzation $397M $410M $211M $123M $235M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$222M -$351M -$79M -$247M --
Change in Inventories $6M -$11M $23M $13M $31M
Cash From Operations $430M $161M $304M $369M $310M
 
Capital Expenditures $210M $217M $154M $137M $180M
Cash Acquisitions $21M $15M $20M $13M $97M
Cash From Investing -$249M -$337M -$278M -$99M -$251M
 
Dividends Paid (Ex Special Dividend) $86M $89M $85M $92M $104M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $495M $407M $273M $61M --
Long-Term Debt Repaid -$500M -$462M -$268M -$196M --
Repurchase of Common Stock $43M $178M $56M $78M $264M
Other Financing Activities -$64M $10M -$39M -$37M --
Cash From Financing -$198M -$312M -$144M -$353M -$419M
 
Beginning Cash (CF) $4.3B $2.8B $3.3B $3.6B $4.2B
Foreign Exchange Rate Adjustment -$35M -$6M $9M -$31M $8M
Additions / Reductions -$52M -$494M -$109M -$114M -$352M
Ending Cash (CF) $4.2B $2.3B $3.2B $3.4B $3.9B
 
Levered Free Cash Flow $220M -$56M $150M $232M $130M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
79
SPHR alert for Feb 14

Sphere Entertainment Co. [SPHR] is down 0.2% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock